Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02975297 · ClinicalTrials.gov registry record · Phase 1
Exenatide Once Weekly for Smoking Cessation
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
NCT02975297 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 84 participants.
The verdict
NCT02975297, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to identify a potential new treatment for smoking cessation.
Interventions
- DRUG Placebo
- BEHAVIORAL Counseling
- DRUG Exenatide
- DRUG NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-01-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02975297
The ClinicalTrials.gov registry entry for NCT02975297 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02975297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02975297 about?
NCT02975297 is a clinical study titled "Exenatide Once Weekly for Smoking Cessation". The purpose of this study is to identify a potential new treatment for smoking cessation.
What is the current status of trial NCT02975297?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2016-07. Estimated completion is 2020-01-03.
What interventions are being tested in trial NCT02975297?
The interventions under investigation include: Placebo (DRUG), Counseling (BEHAVIORAL), Exenatide (DRUG), NRT (DRUG).
Who is sponsoring clinical trial NCT02975297?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.